Oral administration of collagen conjugated with cholera toxin induces tolerance to type II collagen and suppresses chondritis in an animal model of autoimmune ear disease

Annals of Otology, Rhinology and Laryngology

Volumn 110, Issue 7 I, 2001, Pages 646-654

  Kim, N ^a   Kuang Chuan Cheng, ^a   Soon Seog Kwon, ^a   Mora, R ^a   Barbieri, M ^a   Yoo, T J ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Cholera toxin B subunit; Chondritis; Oral tolerance; Type II collagen

Indexed keywords

CHOLERA TOXIN B SUBUNIT; COLLAGEN; COLLAGEN TYPE 2; CYANOGEN BROMIDE; PEPTIDE DERIVATIVE;

ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CHONDRITIS; DRUG EFFECT; EAR DISEASE; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANIMALS; AUTOIMMUNE DISEASES; CHOLERA TOXIN; COLLAGEN; CYANOGEN BROMIDE; EAR DISEASES; IMMUNE TOLERANCE; MICE; MICE, INBRED STRAINS; OSTEOCHONDRITIS; PEPTIDES;

EID: 0034939162     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940111000710     Document Type: Article

References (50)

1. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments
2. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein
3. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy
4. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig
5. + T lymphocytes
6. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit
7. Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats
8. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen
9. Suppression of collagen induced arthritis by oral administration of type II collagen: Changes in immune and arthritic responses mediated by peripheral suppression
10. Tolerance induction by a poorly arthritogenic collagen II can prevent collagen-induced arthritis
11. Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope
12. Suppression of murine collagen-induced arthritis by nasal administration of collagen
13. Induction of oral tolerance to S antigen induced experimental autoimmune uveitus by a uveitogenic 20 merpeptide
14. Suppression of experimental autoimmune uveitis in rats by the oral administration of the uveitopathogenic S-antigen fragment or a cross-reactive homologous peptide
15. Inhibition of experimental autoimmune uveoretinitis by oral administration of S-antigen and synthetic peptides
16. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin
17. A cholera toxoidinsulin conjugate as an oral vaccine against spontaneous autoimmune diabetes
18. Inhibition of murine lymphocyte proliferation by the B subunit of cholera toxin
19. Morphologic and functional alternations of mucosal T cells by cholera toxin and its B subunit
20. The immunological consequences of feeding cholera toxin. I. Feeding cholera toxin suppresses the induction of systemic delayed-type hypersensitivity but not humoral immunity
21. Autoimmunity to type II collagen: An experimental model of arthritis
22. Induction of arthritis in monkeys by immunization with type II collagen
23. Auricular chondritis in rats. An experimental model of relapsing polychondritis induced with type II collagen
24. Type II collagen autoimmunity in otosclerosis and Meniere's disease
25. Type II collagen-induced autoimmune inner ear lesions in guinea pigs
26. Type II collagen-induced autoimmune otospongiosis. A preliminary report
27. Type II collagen-induced autoimmune sensorineural hearing loss and vestibular dysfunction in rats
28. Type II collagen-induced autoimmune endolymphatic hydrops in guinea pig
29. Epitope specificity and T cell receptor usage in type II collagen induced autoimmune ear disease
30. Collagen-induced arthritis in mice. Localization of an arthritogenic determinant to a fragment of the type II collagen molecule
31. Covalent structure of collagen: Amino acid sequence of an arthritogenic cyanogen bromide peptide from type II collagen of bovine cartilage
32. Protein thiolation and reversible protein-protein conjugation
33. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage
34. Antigen-driven bystander suppression after oral administration of antigens
35. Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen
36. Molecular basis of type II collagen autoimmune disease: Observations of arthritis, auricular chondritis and tympanitis in mice
37. Type II collagen-induced autoimmune ear disease in mice: A preliminary report on an epitope of the type II collagen molecule that induced inner ear lesions
38. Cholera toxin B subunit: An efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance
39. Cholera toxin B subunit as transmucosal carrier-delivery and immunomodulating system for induction of antiinfectious and antipathological immunity
40. Oral tolerance. Immune mechanisms and treatment of autoimmune diseases
41. Effects of oral administration of type II collagen on rheumatoid arthritis
42. Identification and characterization of a major tolerogenic T-cell epitope of type II collagen that suppresses arthritis in B 10.RIII mice
43. r): Identification of an arthritogenic T-cell determinant
44. T cell epitopes of type II collagen that regulate murine collagen-induced arthritis
45. Characterization of the T cell determinants in the induction of autoimmune arthritis by bovine α1 (II)-CB11 in H-2q mice
46. Oral tolerance to myelin basic protein induces regulatory TGF-β-secreting T cells in Peyer's patches of SJL mice
47. High dose oral tolerance in ovalbumin TCR transgenic mice: Systemic neutralization of IL- 12 augments TGF-β secretion and T cell apoptosis
48. Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-γ production and evokes local immunological memory
49. γ-Interferon-induced activation of latent transforming growth factor-β by human monocytes
50. Specific T-cell tolerance may reflect selective activation of lymphokine synthesis